Research that develops us all
We are building a clinic from the start where research and practice evolve together — to optimise mental health through understanding, over time.
A clinic built on scientific curiosity
Research on precision therapy, psychotherapy and augmented treatment is developing rapidly. We follow it carefully — and contribute where we can — to continuously improve how we understand and treat mental ill-health.
From the outset, Nūvai has deliberately created an AI infrastructure that facilitates and streamlines the collection and analysis of data, both our own and that of other actors.
Current research collaborations
REAL-KET is a Swedish observational study from Lund University evaluating the effects of ketamine in various clinical settings. For more information;
Want to go deeper?
Precision therapy
Precision therapy combines evidence-based psychotherapy with in-depth mapping, systematic follow-up and individual adaptation. Research shows that personally adapted interventions can produce better outcomes than standardised approaches, even though the field is still developing.
Ketamine-assisted therapy
Ketamine can provide rapid symptom relief in treatment-resistant depression. Research on ketamine combined with structured psychotherapy (KAP) is promising, but still developing. That is why we follow treatment outcomes systematically and adapt the approach to each individual.
Psychological flexibility
Psychological flexibility is about being able to meet difficult thoughts and feelings while acting in the direction of what matters. Research shows that greater flexibility is associated with better mental health, functioning and wellbeing.
Breathwork (Soma+IQ)
Soma+IQ comes from Somatic Breathwork and is a body-oriented method that combines guided breathing, somatic exercises and integration. The aim is to increase body contact, presence and emotional processing. Research on breathwork shows promising effects on stress and mental health, but the evidence is still developing.
Always evidence-based
Nūvai is passionate about making current scientific insights accessible in an ethical and responsible way.
Our goal is to make research comprehensible and useful — for other practitioners, clients, loved ones and the wider public alike.
Publications by Nuvai's team and advisors
The Nuvai team and our clinical and scientific advisors are actively involved in research spanning mental health, psychiatry, psychology, neuroscience and psychedelic science. Here we present a selection of publications reflecting the areas of knowledge and research fields that inform our work.
Psychedelic Science
- Sjöström, Claesdotter-Knutsson & Kajonius – Personality Traits Explain the Relationship Between Psychedelic Use and Lower Depression Levels (Scientific Reports, 2024)
- Sjöström, Claesdotter-Knutsson, Gripe, Thor & Kajonius – Adolescent Psychedelic Use, Personality, and Mental Health Outcomes (International Journal of Mental Health and Addiction, 2026)
- Sjöström, Claesdotter-Knutsson & Kajonius – Adverse Outcomes Following Psychedelic Use: Associations with Age and Personality Traits (Child and Adolescent Psychiatry and Mental Health, 2026)
- Kajonius, Sjöström & Claesdotter-Knutsson – Big Five Personality and the Psychedelic Experience (Journal of Psychedelic Studies, 2025)
- Kajonius, Sjöström & Claesdotter-Knutsson – Psychedelic Experiences as Meaningful Life Events and Their Association with Well-Being (Journal of Psychoactive Drugs, 2026)
- Bendz, Schäfer, Sjöström, Sikström & Kajonius – Selection Bias in Psychedelic Research: Comparing Enthusiasts and the General Population (Journal of Psychoactive Drugs, 2026)
- Cohorst & Kajonius – Psychedelic Experiences and Death Anxiety: A Systematic Review and Meta-Analysis (Journal of Psychopharmacology, 2026)
Personality & Precision Assessment
Neuroscience & Psychotherapy
Ketamine & Depression
- Ekstrand, Fattah, Persson et al. – Ketamine as an Alternative to Electroconvulsive Therapy for Depression (KetECT Trial) (International Journal of Neuropsychopharmacology, 2022)
- Movahed Rad & Takamiya – Ketamine or Electroconvulsive Therapy for Severe Depression: The Need for Personalized Management (Humana Press, 2025)
- Holck, Movahed, Westrin et al. – Peripheral Serotonin Levels as a Predictor of Antidepressant Treatment Response (Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2024)
The publications above include research authored or co-authored by members of Nuvai's team and advisor network.
Do you need a research partner?
We have broad expertise and infrastructure to conduct clinical studies for both academia and industry in a quality-assured and efficient way. Within our network we can always find specific expertise when needed.
If you would like to know more, please email info@nuvai.se
Contact us